Male breast cancer is a rare clinical entity, its incidence is much lower than that in women, and is closely related to factors such as family history of breast cancer, BRCA2 gene mutation and increased circulating estrogen levels. The treatment effect of this condition has been significantly improved by the integrated application of multiple treatment modalities that mainly include surgical management, endocrine therapy, chemotherapy and radiotherapy. Here, the authors address the research progress of male breast cancer.